Successful Endovascular Treatment of Acute Portal and Superior Mesenteric Vein Thrombosis in a Non-Cirrhotic Patient

Authors

  • Filipe Nery Clínica do Fígado, Centro Médico de Investigação e Tratamento, Porto, Portugal; Departamento de Imuno-Fisiologia, Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Porto, Portugal https://orcid.org/0000-0001-6644-2985
  • Manuel Teixeira Gomes Unidade de Imagiologia, Hospital dos Lusíadas Porto e Braga, Portugal
  • Pedro Sousa Radiologia, Grupo Dr. Pinto Leite, Porto, Portugal

DOI:

https://doi.org/10.60591/crspmi.555

Keywords:

Portal Vein, Radiology, Interventional, Thrombectomy, Thrombolytic Therapy, Venous Thrombosis

Abstract

Portal vein thrombosis (PVT) in the absence of cirrhosis is an uncommon but potentially life‑threatening condition. It is frequently associated with systemic prothrombotic disorders. Early identification of the underlying cause, evaluation of PVT extension and underlying complications, and appropriate therapeutic intervention are crucial for prognosis. This case describes a 62‑year‑old male presenting with acute abdominal pain, in whom imaging revealed PVT with extension to the superior mesenteric vein, without underlying cirrhosis. Despite prompt anticoagulation, endovascular treatment with catheter‑directed thrombolysis and mechanical thrombectomy was conducted, achieving successful recanalization. Etiological investigation excluded major thrombophilic conditions. Long‑term anticoagulation was maintained with favourable evolution. Non‑cirrhotic PVT requires early diagnosis and individualized management. Endovascular therapy should be considered in selected cases with a dismal prognosis and/or mesenteric involvement.

Downloads

Download data is not yet available.

References

1. Elkrief L, Hernandez-Gea V, Senzolo M, Albillos A, Baiges A, Berzigotti A, et al. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies. Lancet Gastroenterol Hepatol. 2024;9:859-83. doi: 10.1016/S2468-1253(24)00155-9.

2. European Association for the Study of the Liver. Electronic address: easloffice@ easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on vascular diseases of the liver. J Hepatol. 2026;84:399-456. doi: 10.1016/j.jhep.2025.08.001.

3. Plessier A, Esposito-Farese M, Baiges A, Shukla A, Garcia Pagan JC, De Raucourt E, et al. Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications. Am J Hematol. 2022;97:431-9. doi: 10.1002/ajh.26474.

4. Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210-8. doi: 10.1002/hep.23259.

5. Saito H, Sugihara F, Ueda T, Hayashi H, Shirai S, Matsumoto T, et al. Efficacy of endovascular treatment for completely occlusive acute-subacute portal and mesenteric vein thrombosis with severe complications in patients without cirrhosis. Jpn J Radiol. 2023;41:541-50. doi: 10.1007/s11604-022-01377-9.

6. Ueda T, Saito H, Shirai S, Sugihara F, Fujitsuna R, Matsumoto T, et al. Endovascular treatment for acute portal vein thrombosis. Interv Radiol. 2025;10:e20230027. doi: 10.22575/interventionalradiology.2023-0027.

7. Plessier A, Goria O, Cervoni JP, Ollivier I, Bureau C, Poujol-Robert A, et al. Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis. NEJM Evid. 2022;1:EVIDoa2200104.

8. Bureau C, Laurent J, Robic MA, Christol C, Guillaume M, Ruidavets JB, et al. Central obesity is associated with non-cirrhotic portal vein thrombosis. J Hepatol. 2016;64:427-32. doi: 10.1016/j.jhep.2015.08.024.

9. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VIIF. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76:959-74. doi: 10.1016/j.jhep.2021.12.022.

10. Rossle M, Bettinger D, Trebicka J, Klinger C, Praktiknjo M, Sturm L, et al. A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment. Aliment Pharmacol Ther. 2020;52:329-39. doi: 10.1111/apt.15811.

11. Oguslu U, Uyanik SA, Cenkeri HC, Atli E, Yilmaz B, Gumus B. Transhepatic pharmacomechanical thrombectomy of symptomatic acute noncirrhotic, nonmalignant portomesenteric venous thrombosis: midterm results. AJR Am J Roentgenol. 2021;217:418-25. doi: 10.2214/AJR.20.23150.

Downloads

Published

15-04-2026

How to Cite

Nery, F., Teixeira Gomes, M., & Sousa, P. (2026). Successful Endovascular Treatment of Acute Portal and Superior Mesenteric Vein Thrombosis in a Non-Cirrhotic Patient. SPMI Case Reports, 4(Special Issue), 11–15. https://doi.org/10.60591/crspmi.555

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.